ACCESSION: MSBNK-SMB_Measured-HSA032P0072001
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'RA11-pos_487': {'bp': 6477.0, 'sum': 9513.0}, 'RA7-pos_476': {'bp': 5731.0, 'sum': 8066.0}, 'HC21-pos_476': {'bp': 5360.0, 'sum': 8730.0}, 'HC14-pos_472': {'bp': 3588.0, 'sum': 7062.0}, 'RA12-pos_198': {'bp': 3577.0, 'sum': 7611.0}, 'HC7-pos_471': {'bp': 2948.0, 'sum': 5643.0}, 'RA12-pos_210': {'bp': 2751.0, 'sum': 7107.0}, 'QC3-pos_206': {'bp': 2479.0, 'sum': 6131.0}, 'RA9-pos_483': {'bp': 2292.0, 'sum': 3582.0}, 'HC11-pos_483': {'bp': 2232.0, 'sum': 3987.0}, 'RA8-pos_484': {'bp': 2119.0, 'sum': 3204.0}, 'RA22-pos_482': {'bp': 1855.0, 'sum': 3180.0}, 'HC3-pos_270': {'bp': 1561.0, 'sum': 3698.0}, 'HC23-pos_464': {'bp': 1341.0, 'sum': 2454.0}, 'QC3-pos_489': {'bp': 1302.0, 'sum': 2015.0}, 'HC24-pos_486': {'bp': 1238.0, 'sum': 2357.0}, 'RA23-pos_456': {'bp': 1179.0, 'sum': 2116.0}, 'QC5-pos_494': {'bp': 1143.0, 'sum': 1500.0}, 'QC1-pos_480': {'bp': 937.0, 'sum': 1962.0}, 'RA10-pos_486': {'bp': 902.0, 'sum': 1361.0}, 'HC16-pos_178': {'bp': 227.0, 'sum': 363.0}}
COMMENT: RETENTION_TIME_STDEV 0.098
COMMENT: PRECURSOR_M/Z_RAW 72.080794
COMMENT: PRECURSOR_M/Z_STDEV 0.000277
COMMENT: PRECURSOR_IN_MS1 mz 72.080805; int 576.303; delta(ppm) 2.333944
COMMENT: PROPOSED_CHARGE_STATE +1; mz 73.083748; int 12.143; cor 0.741
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.197; C4H9N; [M+H]+; delta(ppm) -0.196979
COMMENT: PROPOSED_MF MS-FINDER 4.114; C4H9N; [M+H]+; delta(ppm) -0.204304
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.168; C4H9N; [M+H]+; delta(ppm) -0.204304
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H9N; [M+H]+; delta(ppm) -0.204304
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.752; C4H9N; [M+H]+; delta(ppm) -0.204304
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H9N; [M+H]+; delta(ppm) -0.204304
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.143; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; CCN1CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.036; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; CNCC=C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.952; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; C1CC(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.821; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; C1CCNC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.536; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; CC1(CN1)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.696; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; 3-buten-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.561; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; Pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.434; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.401; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.318; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.162; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.848; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; 3-buten-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.774; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.758; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; Pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.737; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.711; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.758; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.341; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.268; CSWPOLMVXVBCSV-UHFFFAOYSA-N; [M+H]+; 2-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.165; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; IGSKHXTUVXSOMB-UHFFFAOYSA-N; [M+H]+; cyclopropylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; QFUSOYKIDBRREL-NSCUHMNNSA-N; [M+H]+; (E)-but-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; VEBLEROFGPOMPB-UHFFFAOYSA-N; [M+H]+; N-methylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; but-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; JDCBWJCUHSVVMN-UHFFFAOYSA-N; [M+H]+; but-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; DLBWPRNUXWYLRN-UHFFFAOYSA-N; [M+H]+; 2-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; HTHMVKNHGOVITA-UHFFFAOYSA-N; [M+H]+; 3-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; PYTANBUURZFYHD-UHFFFAOYSA-N; [M+H]+; 2-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.859; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.832; VXDHQYLFEYUMFY-UHFFFAOYSA-N; [M+H]+; 2-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; VSRXAWSAKJABKW-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -51.252; RWRDLPDLKQPQOW; [M+H]+; Azolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.044; IOXXVNYDGIXMIP; [M+H]+; Allylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -70.456; JDCBWJCUHSVVMN; [M+H]+; 3-Buten-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -71.066; UJGVUACWGCQEAO; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.043; QFUSOYKIDBRREL; [M+H]+; Crotylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -81.602; ASVKKRLMJCWVQF; [M+H]+; 3-Buten-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -91.421; VXDHQYLFEYUMFY; [M+H]+; Methallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -100.432; VEBLEROFGPOMPB; [M+H]+; Cyclopropyl-methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.436; CSWPOLMVXVBCSV; [M+H]+; Butyleneimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.523; IGSKHXTUVXSOMB; [M+H]+; Cyclopropylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.353; KZZKOVLJUKWSKX; [M+H]+; Cyclobutanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.151; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.352; PYTANBUURZFYHD; [M+H]+; Cyclopropanamine, 2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.998; HNPYZRNUMNPTAQ; [M+H]+; Dimethyl aziridinium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -160.500; VSRXAWSAKJABKW; [M+H]+; Ambcb4021534
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.300; RWRDLPDLKQPQOW; [M+H]+; Azolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -53.316; UJGVUACWGCQEAO; [M+H]+; 1-Ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.500; QFUSOYKIDBRREL; [M+H]+; 2-Butenylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.623; IOXXVNYDGIXMIP; [M+H]+; Methyl(prop-2-enyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.309; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.100; RWRDLPDLKQPQOW; [M+H]+; 2,2,3-Trideuteriopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -99.606; VXDHQYLFEYUMFY; [M+H]+; 2-Methylallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.647; CSWPOLMVXVBCSV; [M+H]+; 2-Ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.406; JDCBWJCUHSVVMN; [M+H]+; 2-Deuteriobut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.895; HNPYZRNUMNPTAQ; [M+H]+; 1,1-Dimethylaziridinium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.711; IGSKHXTUVXSOMB; [M+H]+; Cyclopropanemethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.236; UJGVUACWGCQEAO; [M+H]+; 1-Ethylaziridine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H10N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.823
MS$FOCUSED_ION: PRECURSOR_M/Z 72.080761
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9000000000-ba702f50fe1b4d94fcd2
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  28.0190323 62.9123 28.019322 26.9103 32.14 0.7827 15 f{C1H2N1}/30.58ppm,p-C3H8
  29.0139439 71.0731 29.014238 24.9191 27.55 0.7981 18 ?
  30.0347183 175.8846 30.035016 22.7736 70.21 0.8789 18 f{C1H4N1}/29.73ppm,p-C3H6
  42.0341760 103.1240 42.034487 22.1486 70.62 0.4726 19 f{C2H4N1}/8.34ppm,p-C2H6
  44.0500581 73.7219 44.050366 17.7071 27.33 0.8423 17 f{C2H6N1}/13.22ppm,p-C2H4
  72.0817943 999.0000 72.081952 15.8847 0.00 1.0000 21 f{C4H10N1}/14.13ppm,p
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  28.019032 62.91 62
  29.013944 71.07 71
  30.034718 175.88 175
  42.034176 103.12 103
  44.050058 73.72 73
  72.081794 999.00 999
//
